Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system
- PMID: 19809782
- DOI: 10.1007/s00534-009-0187-2
Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system
Abstract
Background: The main etiology of NAFLD and NASH after pancreatic resection is still unclear, and the therapeutic strategy has yet to be established. The focus of this review is how predict and prevent NAFLD/NASH after pancreaticoduodenectomy.
Methods: From April 2005 to October 2008, 54 patients who underwent pancreaticoduodenectomy in our institution were enrolled in this study. From the pre-, intra- and postoperative risk factors, we identified the most influential risk factors of postoperative NAFLD by uni- and multivariate analyses. Moreover, a postoperative NAFLD scoring system was proposed based on these risk factors.
Results: The incidence of postoperative NAFLD was 37.0% (20/54). Of these, 10% (2/20) of patients were diagnosed as having NASH by percutaneous liver biopsy. By multivariate analysis, pancreatic adenocarcinoma (p < 0.05), pancreatic resection line (p < 0.01) and postoperative diarrhea (p < 0.01) were identified as the most influential factors concerning postoperative NAFLD. Based on these results, we proposed a postoperative NAFLD scoring system (0-10) and evaluated the correlation between the score and decreasing rates of CT values, revealing a significant correlation (r = 0.829 p < 0.001). The prevalence of postoperative NAFLD in the patients with our scores of 0-3, 4-6 and 7-10 points was 0 (0/22), 35 (6/17) and 93% (14/15), respectively.
Conclusions: In conclusion, NAFLD develops frequently in patients who undergo PD, and some patients even progress to NASH. A postoperative NAFLD scoring system makes it possible to predict the occurrence of NAFLD after PD, and aggressive nutrition support is needed for patients with high scores.
Similar articles
-
Evaluation of predictive factors in patients with nonalcoholic fatty liver disease after pancreaticoduodenectomy.Am Surg. 2014 May;80(5):500-4. Am Surg. 2014. PMID: 24887731
-
Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy.J Hepatobiliary Pancreat Sci. 2014 Mar;21(3):186-92. doi: 10.1002/jhbp.14. Epub 2013 Jun 20. J Hepatobiliary Pancreat Sci. 2014. PMID: 23798362 Clinical Trial.
-
Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.J Gastroenterol. 2011 Jun;46(6):758-68. doi: 10.1007/s00535-011-0370-5. Epub 2011 Jan 26. J Gastroenterol. 2011. PMID: 21267748
-
Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.Transplantation. 2019 Nov;103(11):e345-e354. doi: 10.1097/TP.0000000000002916. Transplantation. 2019. PMID: 31415032
-
Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.Eur J Gastroenterol Hepatol. 2010 Jun;22(6):643-50. doi: 10.1097/MEG.0b013e32832ca0cb. Eur J Gastroenterol Hepatol. 2010. PMID: 19478676 Review.
Cited by
-
Recent trends in organ-preserving pancreatectomy: Its problems and clinical advantages compared with other standard pancreatectomies.Ann Gastroenterol Surg. 2023 Oct 8;8(1):8-20. doi: 10.1002/ags3.12746. eCollection 2024 Jan. Ann Gastroenterol Surg. 2023. PMID: 38250689 Free PMC article. Review.
-
Effect of pancreaticoduodenectomy on the course of hepatic steatosis.World J Surg. 2010 Sep;34(9):2122-7. doi: 10.1007/s00268-010-0636-8. World J Surg. 2010. PMID: 20502896
-
Essential updates 2019/2020: Multimodal treatment of localized pancreatic adenocarcinoma: Current topics and updates in survival outcomes and prognostic factors.Ann Gastroenterol Surg. 2021 Mar 8;5(2):132-151. doi: 10.1002/ags3.12427. eCollection 2021 Mar. Ann Gastroenterol Surg. 2021. PMID: 33860134 Free PMC article. Review.
-
Clinical feasibility of duodenum-preserving pancreatic head resection for neuroendocrine tumors of the pancreatic head as an intermediate procedure between enucleation and pancreaticoduodenectomy.Fujita Med J. 2024 Aug;10(3):69-74. doi: 10.20407/fmj.2023-017. Epub 2024 May 29. Fujita Med J. 2024. PMID: 39086721 Free PMC article.
-
De novo non-alcoholic fatty liver disease after pancreatectomy: A systematic review.World J Clin Cases. 2022 Dec 16;10(35):12946-12958. doi: 10.12998/wjcc.v10.i35.12946. World J Clin Cases. 2022. PMID: 36569000 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous